A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
Main Authors: | Tiffany Pascreau, Colas Tcherakian, Benjamin Zuber, Eric Farfour, Marc Vasse, Philippe Lassalle |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Critical Care |
Online Access: | https://doi.org/10.1186/s13054-021-03589-3 |
Similar Items
-
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
by: Nathalie De Freitas Caires, et al.
Published: (2018-10-01) -
Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome
by: Diego Orbegozo, et al.
Published: (2017-09-01) -
The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome
by: Alexandre Gaudet, et al.
Published: (2019-03-01) -
Decrease of the plasmatic endocan cleavage ratio is associated with the hyperinflammatory phenotype of acute respiratory distress syndrome
by: Alexandre Gaudet, et al.
Published: (2019-07-01) -
Endocan Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome
by: Ling Tang, et al.
Published: (2014-01-01)